Page 327 - 00. Complete Version - Progress Report IPEN 2014-2016
P. 327

Materials and Nanotechnology | Progress Report  327








































               Figure 51. Fluorescence spectroscopy of bovine serum albumin biding to gold nanoparticles


               We have also explored the chromophores of      biological affinity with a considerable lack of
               Albumin as a possible internal dosimeter for   toxicity when administered to humans. With-
               radiation therapy as follow bellow (Figure 51).  in this context, several studies have been per-
                                                              formed using proteins as nanocarriers. In this
               Development of protein based                   work, we developed protein based nanocarri-
               nanocarriers for the delivery                  ers, using bovine serum albumin or papain
               of radiopharmaceuticals                        as model protein and enzyme respectively, by
                                                              the use of radiation. Unlike conventional path-
               Nanoparticles and nanoparticulate systems      ways, radiation allows the sterilization and
               are considered a breakthrough in several fields   simultaneous crosslinking of the protein in a
               as novel applications and features of common-  single step, without the need for toxic mono-
               ly used materials were brought to light as a re-  mers or crosslinkers that commonly lead to
               sult of the nanostructuration. Biopharmaceu-   undesirable reactions when administered to
               tical and biomedical advantages, including     biological systems. The nanocarriers are being
               site specific delivery are good examples of ad-  radiolabeled with 99mTc by the direct and in-
               vantages that are offered by nanotechnology    direct method, in order to achieve an alterna-
               over conventional systems. At the same pace,   tive system for the delivery of this and oth-
               concerns regarding toxicity emerge as most     er radioisotopes for diagnose and treatment
               molecules or nanoparticles have no biologi-    of a variety of disorders. High radiolabeling
               cal affinity, thus adverse reactions may take   yields with good radiochemical stability have
               place including non-specific toxicity. Within   been identified throughout the experiments
               this context, the seek for biologically-friend-  and further steps concern the assessment of
               ly materials are of highlighted role. Proteins   ex vivo and in vivo biodistribution of the de-
               are biocompatible by nature and hold strong    veloped systems.
   322   323   324   325   326   327   328   329   330   331   332